India to Colombia: Lenalidomide Export Trade Route
India has recorded 8 verified shipments of Lenalidomide exported to Colombia, representing a combined trade value of $3.1M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $392.3K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 74% of total export value with 5 shipments worth $2.3M USD. On the buying side, CIPLA COLOMBIA SAS Y O DEPOSITO UPS is the largest importer in Colombia with $1.3M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Colombia Lenalidomide corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $3.1M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $392.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with lenalidomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 22.2%, placing it at rank #20 among India's top lenalidomide export destinations globally.
On the import side, key buyers of Indian lenalidomide in Colombia include CIPLA COLOMBIA SAS Y O DEPOSITO UPS, CIPLA COLOMBIA SAS, CIPLA COLOMBIA SAS Y/O DEPOSITO UPS and 2 others. CIPLA COLOMBIA SAS Y O DEPOSITO UPS is the single largest importer with 3 shipments valued at $1.3M USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ2
- Primary modeSea freight
- Top portJNPT
Market Position
- Global rank#20
- Annual growth+22.2%
- Demand growth+20.7%
- Regulatory ease77/100
Top 10 Indian Lenalidomide Exporters to Colombia
Showing top 10 of 2 Indian suppliers exporting Lenalidomide to Colombia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $464.0K per shipment | 5 | $2.3M | 73.9% |
| 2 | CIPLA LIMITED Avg $272.8K per shipment | 3 | $818.3K | 26.1% |
This table shows the top 10 of 2 Indian companies exporting lenalidomide to Colombia, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED . CIPLA LIMITED is the dominant supplier with 5 shipments worth $2.3M USD, giving it a 74% market share.
Top 10 Lenalidomide Importers in Colombia
Showing top 10 of 5 known buyers in Colombia receiving Lenalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lenalidomide in Colombia include CIPLA COLOMBIA SAS Y O DEPOSITO UPS, CIPLA COLOMBIA SAS, CIPLA COLOMBIA SAS Y/O DEPOSITO UPS , CIPLA COLOMBIA SAS Y/O DEPOSITO UP , CIPLA COLOMBIA SAS Y O DEPOSITO UP. The largest importer is CIPLA COLOMBIA SAS Y O DEPOSITO UPS, accounting for $1.3M USD across 3 shipments — representing 40% of all lenalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA COLOMBIA SAS Y O DEPOSITO UPS | 3 | $1.3M | 39.9% |
| 2 | CIPLA COLOMBIA SAS | 1 | $929.7K | 29.6% |
| 3 | CIPLA COLOMBIA SAS Y/O DEPOSITO UPS | 2 | $584.7K | 18.6% |
| 4 | CIPLA COLOMBIA SAS Y/O DEPOSITO UP | 1 | $233.6K | 7.4% |
| 5 | CIPLA COLOMBIA SAS Y O DEPOSITO UP | 1 | $138.5K | 4.4% |
Top 10 Lenalidomide Formulations Imported by Colombia
Showing top 10 of 8 product formulations shipped on the India to Colombia Lenalidomide route, ranked by trade value
Colombia imports a wide range of lenalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LENOSIDE 10 MG CAPSULES LENALIDOMIDE 10MG CAPSULES DOCUMENT QTY 3000 PACK 3X7=63000 NOS — accounts for $929.7K USD across 1 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LENOSIDE 10 MG CAPSULES LENALIDOMIDE 10MG CAPSULES DOCUMENT QTY 3000 PACK 3X7=63000 NOS | 1 | $929.7K | 29.6% |
| 2 | LENOSIDE 10MG CAPSULES LENALIDOMIDE 10 | 1 | $902.0K | 28.7% |
| 3 | LENOSIDE 10 MG CAPSULES (LENALIDOMIDE 10 MG CAPSULES). INV.QTY. 1620 PACK 3 X 7'S =34020 NOS | 1 | $309.6K | 9.9% |
| 4 | LENOSIDE 15MG CAPSULES LENALIDOMIDE 15 | 1 | $292.3K | 9.3% |
| 5 | LENOSIDE 10MG CAPSULES (LENALIDOMIDE 10 MG CAPSULES) INV.QTY.1440 PACK 3X7'S=30240 NOS | 1 | $275.1K | 8.8% |
| 6 | LENOSIDE 10MG CAPSULES (LENALIDOMIDE 10 MG CAPSULES) | 1 | $233.6K | 7.4% |
| 7 | LENOSIDE 10MG CAPSULES LENALIDOMIDE 10 MG CAPSULES INV QTY 1440PACK X 3 X 7 S 30240 NOS | 1 | $138.5K | 4.4% |
| 8 | LENOSIDE 15MG CAPSULES LENALIDOMIDE 15 MG CAPSULES 600 PACKx3x7 S 12600 NOS | 1 | $57.5K | 1.8% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT handles the highest volume with 3 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's lenalidomide exports to Colombia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $392.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lenoside 10mg capsules lenalidomide 10 and lenoside 10 mg capsules (lenalidomide 10 mg capsules). inv.qty. 1620 pack 3 x 7's =34020 nos, suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA COLOMBIA SAS Y O DEPOSITO UPS is the largest importer with 3 shipments worth $1.3M USD — representing 40% of all lenalidomide imports from India on this route.
Route Statistics
- Trade Volume
- $3.1M
- Avg. Shipment
- $392.3K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~18 days
- Annual Growth
- +22.2%
Related Analysis
Other Lenalidomide Routes
Unlock the Full India to Colombia Lenalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 8 shipments on this route.
Frequently Asked Questions — India to Colombia Lenalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lenalidomide to Colombia?
The leading Indian exporters of Lenalidomide to Colombia are CIPLA LIMITED, CIPLA LIMITED . CIPLA LIMITED holds the largest market share at approximately 74% of total trade value on this route.
Q What is the total value of Lenalidomide exports from India to Colombia?
India exports Lenalidomide to Colombia worth approximately $3.1M USD across 8 recorded shipments. The average value per shipment is $392.3K USD.
Q Which ports does India use to ship Lenalidomide to Colombia?
The most active port of origin is JNPT with 3 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Colombia for Lenalidomide?
The average transit time for Lenalidomide shipments from India to Colombia is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Colombia Lenalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.2% with demand growth tracking at 20.7%. The route is ranked #20 among India's top Lenalidomide export destinations globally.
Q How many suppliers are active on the India to Colombia Lenalidomide route?
There are currently 2 active Indian suppliers exporting Lenalidomide to Colombia. The market is moderately concentrated with CIPLA LIMITED accounting for 74% of total shipment value.
Q Who are the main importers of Lenalidomide from India in Colombia?
The leading importers of Indian Lenalidomide in Colombia include CIPLA COLOMBIA SAS Y O DEPOSITO UPS, CIPLA COLOMBIA SAS, CIPLA COLOMBIA SAS Y/O DEPOSITO UPS , CIPLA COLOMBIA SAS Y/O DEPOSITO UP , CIPLA COLOMBIA SAS Y O DEPOSITO UP. CIPLA COLOMBIA SAS Y O DEPOSITO UPS is the largest buyer with 3 shipments worth $1.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Colombia export trade corridor identified from Indian Customs (DGFT) records for Lenalidomide.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Colombia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 8 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists